BCL2 and hepatocellular carcinoma: Collectively, these results demonstrate that FPHPE exerts a dual inhibitory effect on hepatocellular carcinoma progression by (i) silencing STAT3 transcriptional output to suppress oncogenic, inflammatory, and metastatic pathways, and (ii) promoting mitochondrial apoptosis through Bax/Bcl2 modulation.